Dara W Frank

US Patent:

6827935, Dec 7, 2004

Filed:

Jan 26, 2001

Appl. No.:

09/770916

Inventors:

Dara W. Frank - West Allis WI
Timothy L. Yahr - Coralville IA
Teiji Sawa - San Francisco CA
Robert B. Fritz - Bay View WI

Assignee:

MCW Research Foundation - Milwaukee WI
Regents of the University of California - Oakland CA

International Classification:

A61K 3940

US Classification:

4241701, 4241301, 4241501, 4241391, 4241641, 5303871, 5303884

Abstract:

A method of inhibiting, moderating or diagnosing infection is disclosed. In one embodiment, this method comprises inoculating a patient with an effective amount of PcrV antigen.

US Patent:

7494653, Feb 24, 2009

Filed:

Jan 25, 2002

Appl. No.:

10/496059

Inventors:

Dara W. Frank - West Allis WI, US
Timothy L. Yahr - Solon IA, US
Teiji Sawa - San Francisco CA, US
Robert B. Fritz - Milwaukee WI, US

Assignee:

MCW Research Foundation, Inc. - Milwaukee WI
The Regents of the University of California - Oakland CA

International Classification:

A61K 39/40

US Classification:

4241701, 4241301, 4241391, 4241501, 4241641, 5303871, 5303881

Abstract:

A method of inhibiting, moderating or diagnosing infection is disclosed. In one embodiment, this method comprises inoculating a patient with an effective amount of PcrV antigen.

US Patent:

8101347, Jan 24, 2012

Filed:

Jan 16, 2009

Appl. No.:

12/355614

Inventors:

Dara W. Frank - West Allis WI, US
Timothy L. Yahr - Coralville IA, US
Teiji Sawa - San Francisco CA, US
Robert B. Fritz - Milwaukee WI, US

Assignee:

MCW Research Foundation, Inc. - Milwaukee WI

International Classification:

C12Q 1/68

US Classification:

435 6, 536 237, 536 243, 536 2432, 536 2433

Abstract:

A method of inhibiting, moderating or diagnosing infection is disclosed. In one embodiment, this method comprises inoculating a patient with an effective amount of PcrV antigen.

US Patent:

55996655, Feb 4, 1997

Filed:

Dec 21, 1993

Appl. No.:

8/171299

Inventors:

Joseph T. Barbieri - New Berlin WI
Dara W. Frank - West Allis WI
Scott M. Kulich - West Allis WI

Assignee:

MCW Research Foundation - Milwaukee WI

International Classification:

C12Q 168
C12N 1585

US Classification:

435 6

Abstract:

A genetic construct containing a coding region for exoenzyme S activity from Pseudomonas aeruginosa is disclosed. A essentially pure protein preparation of the 49 kDa form of exoenzyme S is also disclosed. The protein product of the genetic construct may be used to modify the RAS protein function in mammalian carcinomas, used as a vaccine, or used to diagnose Pseudomonas aeruginosa infection.

US Patent:

6309651, Oct 30, 2001

Filed:

Nov 23, 1999

Appl. No.:

9/448339

Inventors:

Dara W. Frank - West Allis WI
Timothy L. Yahr - Hanover NH
Teiji Sawa - San Francisco CA

Assignee:

MCW Research Foundation - Milwaukee WI
The Regents of the University of California - Oakland CA

International Classification:

A61K 3908

US Classification:

4242601

Abstract:

A method of inhibiting, moderating or diagnosing Pseudomonas aeruginosa infection is disclosed. In one embodiment, this method comprises inoculating a patient with an effective amount of PcrV antigen.